154 related articles for article (PubMed ID: 6332516)
1. Bepridil for recurrent sustained ventricular tachycardias: assessment using electrophysiologic testing.
Levy S; Cointe R; Metge M; Faugere G; Valeix B; Gerard R
Am J Cardiol; 1984 Sep; 54(6):579-81. PubMed ID: 6332516
[TBL] [Abstract][Full Text] [Related]
2. [Oral and intravenous bepridil in the treatment of recurrent sustained ventricular tachycardias. Electropharmacological study].
Lévy S; Metge M; Cointe R; Labrunie P; Valeix P; Gérard R
Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():63-6. PubMed ID: 3938261
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiologic and antiarrhythmic properties of bepridil.
Prystowsky EN
Am J Cardiol; 1985 Mar; 55(7):59C-62C. PubMed ID: 3872056
[TBL] [Abstract][Full Text] [Related]
4. Prolongation of QT interval and antiarrhythmic action of bepridil.
Somberg J; Torres V; Flowers D; Miura D; Butler B; Gottlieb S
Am Heart J; 1985 Jan; 109(1):19-27. PubMed ID: 3871296
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of bepridil efficacy by electrophysiologic testing in patients with recurrent ventricular tachycardia: comparison of two regimens.
Brembilla-Perrot B; Aliot E; Clementy J; Cosnay P; Djiane P; Fauchier JP; Kacet S; Lellouche D; Mabo P; Richard M
Cardiovasc Drugs Ther; 1992 Apr; 6(2):187-93. PubMed ID: 1390333
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiologic effects and long-term efficacy of bepridil for recurrent supraventricular tachycardias.
Roy D; Montigny M; Klein GJ; Sharma AD; Cassidy D
Am J Cardiol; 1987 Jan; 59(1):89-92. PubMed ID: 3492906
[TBL] [Abstract][Full Text] [Related]
7. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
Horowitz LN; Josephson ME; Farshidi A; Spielman SR; Michelson EL; Greenspan AM
Circulation; 1978 Dec; 58(6):986-97. PubMed ID: 709782
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of supraventricular and paroxysmal ventricular tachycardia with bepridil].
Fauchier JP; Cosnay P; Néel C; Rouesnel P; Bonnet P; Quilliet L
Arch Mal Coeur Vaiss; 1985 Apr; 78(4):612-9. PubMed ID: 3923987
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiologic effects of bepridil in patients with refractory ventricular tachycardia assessed by programmed electrical stimulation.
Schmitt C; Brachmann J; Hölzel C; Waldecker B; Schöls W; Beyer T; Kübler W
Clin Cardiol; 1990 Dec; 13(12):864-8. PubMed ID: 2282730
[TBL] [Abstract][Full Text] [Related]
10. The effect of bepridil, verapamil, and quinidine in the prevention of ventricular tachycardia induced by programmed electrical stimulation in the digitalized dog.
Keren G; Tepper D; Butler B; Torres V; Somberg JC
Am Heart J; 1984 Nov; 108(5):1236-43. PubMed ID: 6333809
[TBL] [Abstract][Full Text] [Related]
11. Clinical and electrophysiologic assessment of oral flecainide acetate for recurrent ventricular tachycardia: evidence for exacerbation of electrical instability.
Oetgen WJ; Tibbits PA; Abt ME; Goldstein RE
Am J Cardiol; 1983 Oct; 52(7):746-50. PubMed ID: 6624666
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiologic evaluation of pirmenol for sustained ventricular tachycardia secondary to coronary artery disease.
Easley AR; Mann DE; Reiter MJ; Sakun V; Sullivan SM; Magro SA; Luck JC; Wyndham CR
Am J Cardiol; 1986 Jul; 58(1):86-9. PubMed ID: 3728337
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of recurrent ventricular tachycardias using oral propafenone].
Cointe R; Lévy S; Metge M; Vrancea F; Labrunie P; Valeix B; Gérard R
Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():59-62. PubMed ID: 3938260
[TBL] [Abstract][Full Text] [Related]
15. Effect of intravenous and oral flecainide on ventricular tachycardia.
Ward DE; Cheesman M; Dancy M
Int J Cardiol; 1986 Mar; 10(3):251-62. PubMed ID: 3957470
[TBL] [Abstract][Full Text] [Related]
16. [Electrophysiological evaluation of the treatment of patients with recurrent ventricular tachycardia].
Mendoza I; Moleiro F; Castellanos A; Casal H; Arends E; Medina V
Arch Inst Cardiol Mex; 1982; 52(4):301-11. PubMed ID: 7138133
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiologic and antiarrhythmic actions of bepridil. Comparison with verapamil and ajmaline for atrioventricular reentrant tachycardia.
Rowland E; McKenna WJ; Krikler DM
Am J Cardiol; 1985 Jun; 55(13 Pt 1):1513-9. PubMed ID: 3873867
[TBL] [Abstract][Full Text] [Related]
18. Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia.
Veltri EP; Reid PR; Platia EV; Griffith LS
Am J Cardiol; 1985 Feb; 55(4):375-9. PubMed ID: 3969872
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic sustained left ventricular tachycardia: clinical and electrophysiologic characteristics.
Ohe T; Shimomura K; Aihara N; Kamakura S; Matsuhisa M; Sato I; Nakagawa H; Shimizu A
Circulation; 1988 Mar; 77(3):560-8. PubMed ID: 3342487
[TBL] [Abstract][Full Text] [Related]
20. [Bepridil--electrophysiologic properties of a new calcium antagonist with an anti-arrhythmia effect].
Zehender M; Geibel A; Henning B; Hohnloser S; Meinertz T; Just H
Z Kardiol; 1988 Feb; 77(2):93-8. PubMed ID: 3259053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
